Skip to content
NOTICIAS
PUBLICACIONES
- Future cancer therapy could use immunity to clean up damaged DNA by modulating AUF1
- This daily habit could lower dementia risk by 35%, scientists say
- New guideline aims to reduce severe allergic reactions to epilepsy drugs
- Synthetic DNA vaccine platform elicits potent immunity where electroporated naked-mRNA is non-immunogenic
- Feeder-free generation of functional dendritic cells from human pluripotent stem cells
- Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity?
- Local immunotherapy for the treatment of cancer: scientific advances and clinical potential
- First-in-human single-cell and TCR atlas reveals peripheral immune remodeling before and after irreversible electroporation in prostate cancer
- Correction to: Pre-ligand assembly domain-derived recombinant protein of TNFR2 inhibits the expansion of CD4+ Foxp3+ regulatory T cells on 13 de May de 2026 at 10:00
- A new approach to cancer vaccination yields more powerful T cells
- Nur77 Is Associated With Polyfunctional Properties in Virus‐Specific Human CD8+ T Cells. [[{“value”:”Fabiola Martel,
Daniel Rincón,
Caroline Passaes,
Leonardo Arévalo,
Marcela Torres,
Natalia Ramirez,
Carlos F. Narváez,
Jessica F. Toro,
Otto Sussmann,
Manuel A. Franco,
José Mateus,
John Sidney,
Alessandro Sette,
Asier Sáez‐Cirión,
Federico Perdomo‐Celis”}]]
- dNK3 cells in normal pregnancy and recurrent pregnancy loss: from molecular identity to functional imbalance
- Buprenorphine extended-release (Ethiqa XR) impacts the immunological response in mice exposed to aerosolized Burkholderia pseudomallei or Yersinia pestis
- Clinical characteristics and long-term prognosis of talaromycosis in children with novel and reported inborn errors of immunity
- Lactylation-mediated remodelling of the breast cancer microenvironment: single-cell multidimensional analysis and prognostic model construction
- Beyond the usual suspects: rethinking post-stroke immunosuppression
- Sex-specific reporting patterns and onset timing of immune-related adverse events associated with nivolumab and pembrolizumab: a dual-database pharmacovigilance analysis
- miRNA profiling shows shared signatures in pediatric asthma, obesity and their comorbidity
- The inhibition of the Aβ-ASC interaction site suppresses β-amyloid aggregation and cytotoxicity
- Convergent death programs in chronic obstructive pulmonary disease: how pyroptotic and ferroptotic crosstalk reshapes therapeutic paradigms
- The role of the complement system in gastrointestinal-related diseases
- Hyperthermia enhances the efficacy of PD-1 inhibitor plus chemotherapy in PD-L1 CPS-negative advanced gastric cancer
- Peripheral nerve remodeling in the tumor microenvironment: neuro-immune crosstalk, molecular mechanisms, and precision therapeutic
- Generation of functional canine TIL products for solid tumors
- Neutrophil extracellular traps in gout: from immune defense to pathological dynamic equilibrium
- Serum inflammatory cytokines in the progression of depression
- Complement activation in patients with post-acute sequelae after SARS-CoV-2 infection
- Serplulimab combined with gemcitabine, nab-paclitaxel, and stereotactic body radiotherapy versus gemcitabine and nab-paclitaxel as first-line treatment for recurrent or metastatic pancreatic ductal adenocarcinoma: a randomized, open-label, multicenter, phase III clinical trial (WGOG-PAN 006/ICSBR-2)
- Risk of intestinal involvement in mucocutaneous-onset Behçet’s disease: data from the AIDA network registry
- Editorial: Understanding eQTLs and their Association with Spondyloarthropathies
- Divergent immune cascades activated by metabolic versus mechanical exercise intensity: revisiting cytokine heterogeneity in “moderate-intensity exercise”
- Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities
